Skip to search formSkip to main contentSkip to account menu

cisplatin liposomal

Known as: Cisplatin, Liposomal, Liposomal Cisplatin 
A synthetic formulation in which the antineoplastic agent cisplatin is encapsulated in lipids. Cisplatin liposomal consists of small aggregates of… 
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Cisplatin

Narrower (2)

SPI-77, liposomalStealth liposomal cisplatin

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Meta-analysis of clinical trials comparing the efficacy and safety of liposomal cisplatin versus conventional nonliposomal cisplatin in nonsmall cell lung cancer (NSCLC) and squamous cell carcinoma…
Background: While liposomal cisplatin has shown enhanced drug tolerability and higher targeting property as compared with the… 
Review
2009
Review
2009
Clinical overview on Lipoplatin™: a successful liposomal formulation of cisplatin
  • T. Boulikas
  • Expert Opinion on Investigational Drugs
  • 2009
  • Corpus ID: 27655302
Nanoparticle formulations for packaging existing drugs have been used to treat cancer. Lipoplatin™ is a liposomal cisplatin… 
1999
1999
Antitumor activity of Herceptin in combination with STEALTH liposomal cisplatin or nonliposomal cisplatin in a HER2 positive human breast cancer model.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)